|
|
|
|
|
|
|
|
|
|
|
|
|
| • | Highly
immunogenic |
|||||||||||
| • | 97%-100% of
children, adolescents, and adults |
|||||||||||
| have
protective levels of antibody within 1 |
||||||||||||
| month of
receiving first dose; essentially |
||||||||||||
| 100% have
protective levels after second dose |
||||||||||||
| • | Highly
efficacious |
|||||||||||
| • | In published
studies, 94%-100% of children |
|||||||||||
| protected
against clinical hepatitis A after |
||||||||||||
| equivalent of
one dose |
||||||||||||